Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9 G Korkmaz, R Lopes, AP Ugalde, E Nevedomskaya, R Han, K Myacheva, ... Nature biotechnology 34 (2), 192-198, 2016 | 471 | 2016 |
Recent advances in prostate cancer treatment and drug discovery E Nevedomskaya, SJ Baumgart, B Haendler International journal of molecular sciences 19 (5), 1359, 2018 | 289 | 2018 |
CopywriteR: DNA copy number detection from off-target sequence data T Kuilman, A Velds, K Kemper, M Ranzani, L Bombardelli, M Hoogstraat, ... Genome biology 16, 1-15, 2015 | 233 | 2015 |
Integrative epigenetic taxonomy of primary prostate cancer S Stelloo, E Nevedomskaya, Y Kim, K Schuurman, E Valle-Encinas, ... Nature communications 9 (1), 4900, 2018 | 134 | 2018 |
APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer M Periyasamy, H Patel, CF Lai, VTM Nguyen, E Nevedomskaya, A Harrod, ... Cell reports 13 (1), 108-121, 2015 | 130 | 2015 |
Exploratory analysis of human urine by LC–ESI-TOF MS after high intake of olive oil: Understanding the metabolism of polyphenols R García-Villalba, A Carrasco-Pancorbo, E Nevedomskaya, ... Analytical and Bioanalytical Chemistry 398, 463-475, 2010 | 120 | 2010 |
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis S Stelloo, E Nevedomskaya, Y Kim, L Hoekman, OB Bleijerveld, T Mirza, ... Oncogene 37 (3), 313-322, 2018 | 110 | 2018 |
Gas chromatography/atmospheric pressure chemical ionization-time of flight mass spectrometry: analytical validation and applicability to metabolic profiling A Carrasco-Pancorbo, E Nevedomskaya, T Arthen-Engeland, T Zey, ... Analytical Chemistry 81 (24), 10071-10079, 2009 | 102 | 2009 |
Loss of androgen receptor signaling in prostate cancer‐associated fibroblasts (CAFs) promotes CCL2‐and CXCL8‐mediated cancer cell migration B Cioni, E Nevedomskaya, MHM Melis, J van Burgsteden, S Stelloo, ... Molecular oncology 12 (8), 1308-1323, 2018 | 97 | 2018 |
Androgen receptor profiling predicts prostate cancer outcome S Stelloo, E Nevedomskaya, HG van der Poel, J de Jong, ... EMBO molecular medicine 7 (11), 1450-1464, 2015 | 94 | 2015 |
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models T Sugawara, SJ Baumgart, E Nevedomskaya, K Reichert, H Steuber, ... International Journal of Cancer 145 (5), 1382-1394, 2019 | 75 | 2019 |
Alignment of capillary electrophoresis–mass spectrometry datasets using accurate mass information E Nevedomskaya, R Derks, AM Deelder, OA Mayboroda, M Palmblad Analytical and bioanalytical chemistry 395, 2527-2533, 2009 | 71 | 2009 |
Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells C Koufaris, GN Valbuena, Y Pomyen, GD Tredwell, E Nevedomskaya, ... Oncogene 35 (21), 2766-2776, 2016 | 68 | 2016 |
Evaluation of GC-APCI/MS and GC-FID as a complementary platform T Pacchiarotta, E Nevedomskaya, A Carrasco-Pancorbo, AM Deelder, ... Journal of biomolecular techniques: JBT 21 (4), 205, 2010 | 63 | 2010 |
CE-MS for metabolic profiling of volume-limited urine samples: application to accelerated aging TTD mice E Nevedomskaya, R Ramautar, R Derks, I Westbroek, G Zondag, ... Journal of proteome research 9 (9), 4869-4874, 2010 | 61 | 2010 |
Metabolic profiling of human urine by CE-MS using a positively charged capillary coating and comparison with UPLC-MS R Ramautar, E Nevedomskaya, OA Mayboroda, AM Deelder, ID Wilson, ... Molecular BioSystems 7 (1), 194-199, 2011 | 60 | 2011 |
Optimized ChIP-seq method facilitates transcription factor profiling in human tumors AA Singh, K Schuurman, E Nevedomskaya, S Stelloo, S Linder, M Droog, ... Life science alliance 2 (1), 2019 | 54 | 2019 |
VAV3 mediates resistance to breast cancer endocrine therapy H Aguilar, A Urruticoechea, P Halonen, K Kiyotani, T Mushiroda, X Barril, ... Breast Cancer Research 16, 1-16, 2014 | 50 | 2014 |
Explorative analysis of urine by capillary electrophoresis-mass spectrometry in chronic patients with complex regional pain syndrome R Ramautar, AA van der Plas, E Nevedomskaya, RJE Derks, GW Somsen, ... Journal of proteome research 8 (12), 5559-5567, 2009 | 45 | 2009 |
Characterization of the Menin-MLL interaction as therapeutic cancer target K Brzezinka, E Nevedomskaya, R Lesche, A Haegebarth, A Ter Laak, ... Cancers 12 (1), 201, 2020 | 40 | 2020 |